Myomo (MYO) Q2 FY26 earnings call

Myomo delivered a strong second quarter, marked by significant revenue growth and improved profitability, primarily driven by the successful shift to recurring patient referral sources. The company raised its full-year revenue guidance and demonstrated operating leverage, while continuing to invest in product innovation and clinical research. Management expressed confidence in its strategic pillars to drive future growth and achieve sustainable positive cash flows.